Cargando…
Reactive Oxygen Species-Responsive Nanococktail With Self-Amplificated Drug Release for Efficient Co-Delivery of Paclitaxel/Cucurbitacin B and Synergistic Treatment of Gastric Cancer
Application of drug combinations is a powerful strategy for the therapy of advanced gastric cancer. However, the clinical use of such combinations is greatly limited by the occurrence of severe systemic toxicity. Although polymeric-prodrug-based nanococktails can significantly reduce toxicity of dru...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8931329/ https://www.ncbi.nlm.nih.gov/pubmed/35308794 http://dx.doi.org/10.3389/fchem.2022.844426 |
_version_ | 1784671234829582336 |
---|---|
author | Pang, Lijun Zhang, Lei Zhou, Hong Cao, Ling Shao, Yueqin Li, Tengyun |
author_facet | Pang, Lijun Zhang, Lei Zhou, Hong Cao, Ling Shao, Yueqin Li, Tengyun |
author_sort | Pang, Lijun |
collection | PubMed |
description | Application of drug combinations is a powerful strategy for the therapy of advanced gastric cancer. However, the clinical use of such combinations is greatly limited by the occurrence of severe systemic toxicity. Although polymeric-prodrug-based nanococktails can significantly reduce toxicity of drugs, they have been shown to have low intracellular drug release. To balance between efficacy and safety during application of polymeric-prodrug-based nanococktails, a reactive oxygen species (ROS)-responsive nanococktail (PCM) with self-amplification drug release was developed in this study. In summary, PCM micelles were co-assembled from ROS-sensitive cucurbitacin B (CuB) and paclitaxel (PTX) polymeric prodrug, which were fabricated by covalently grafting PTX and CuB to dextran via an ROS-sensitive linkage. To minimize the side effects of the PCM micelles, a polymeric-prodrug strategy was employed to prevent premature leakage. Once it entered cancer cells, PCM released CuB and PTX in response to ROS. Moreover, the released CuB further promoted ROS generation, which in turn enhanced drug release for better therapeutic effects. In vivo antitumor experiments showed that the PCM-treated group had lower tumor burden (tumor weight was reduced by 92%), but bodyweight loss was not significant. These results indicate that the developed polymeric prodrug, with a self-amplification drug release nanococktail strategy, can be an effective and safe strategy for cancer management. |
format | Online Article Text |
id | pubmed-8931329 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-89313292022-03-19 Reactive Oxygen Species-Responsive Nanococktail With Self-Amplificated Drug Release for Efficient Co-Delivery of Paclitaxel/Cucurbitacin B and Synergistic Treatment of Gastric Cancer Pang, Lijun Zhang, Lei Zhou, Hong Cao, Ling Shao, Yueqin Li, Tengyun Front Chem Chemistry Application of drug combinations is a powerful strategy for the therapy of advanced gastric cancer. However, the clinical use of such combinations is greatly limited by the occurrence of severe systemic toxicity. Although polymeric-prodrug-based nanococktails can significantly reduce toxicity of drugs, they have been shown to have low intracellular drug release. To balance between efficacy and safety during application of polymeric-prodrug-based nanococktails, a reactive oxygen species (ROS)-responsive nanococktail (PCM) with self-amplification drug release was developed in this study. In summary, PCM micelles were co-assembled from ROS-sensitive cucurbitacin B (CuB) and paclitaxel (PTX) polymeric prodrug, which were fabricated by covalently grafting PTX and CuB to dextran via an ROS-sensitive linkage. To minimize the side effects of the PCM micelles, a polymeric-prodrug strategy was employed to prevent premature leakage. Once it entered cancer cells, PCM released CuB and PTX in response to ROS. Moreover, the released CuB further promoted ROS generation, which in turn enhanced drug release for better therapeutic effects. In vivo antitumor experiments showed that the PCM-treated group had lower tumor burden (tumor weight was reduced by 92%), but bodyweight loss was not significant. These results indicate that the developed polymeric prodrug, with a self-amplification drug release nanococktail strategy, can be an effective and safe strategy for cancer management. Frontiers Media S.A. 2022-03-04 /pmc/articles/PMC8931329/ /pubmed/35308794 http://dx.doi.org/10.3389/fchem.2022.844426 Text en Copyright © 2022 Pang, Zhang, Zhou, Cao, Shao and Li. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Chemistry Pang, Lijun Zhang, Lei Zhou, Hong Cao, Ling Shao, Yueqin Li, Tengyun Reactive Oxygen Species-Responsive Nanococktail With Self-Amplificated Drug Release for Efficient Co-Delivery of Paclitaxel/Cucurbitacin B and Synergistic Treatment of Gastric Cancer |
title | Reactive Oxygen Species-Responsive Nanococktail With Self-Amplificated Drug Release for Efficient Co-Delivery of Paclitaxel/Cucurbitacin B and Synergistic Treatment of Gastric Cancer |
title_full | Reactive Oxygen Species-Responsive Nanococktail With Self-Amplificated Drug Release for Efficient Co-Delivery of Paclitaxel/Cucurbitacin B and Synergistic Treatment of Gastric Cancer |
title_fullStr | Reactive Oxygen Species-Responsive Nanococktail With Self-Amplificated Drug Release for Efficient Co-Delivery of Paclitaxel/Cucurbitacin B and Synergistic Treatment of Gastric Cancer |
title_full_unstemmed | Reactive Oxygen Species-Responsive Nanococktail With Self-Amplificated Drug Release for Efficient Co-Delivery of Paclitaxel/Cucurbitacin B and Synergistic Treatment of Gastric Cancer |
title_short | Reactive Oxygen Species-Responsive Nanococktail With Self-Amplificated Drug Release for Efficient Co-Delivery of Paclitaxel/Cucurbitacin B and Synergistic Treatment of Gastric Cancer |
title_sort | reactive oxygen species-responsive nanococktail with self-amplificated drug release for efficient co-delivery of paclitaxel/cucurbitacin b and synergistic treatment of gastric cancer |
topic | Chemistry |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8931329/ https://www.ncbi.nlm.nih.gov/pubmed/35308794 http://dx.doi.org/10.3389/fchem.2022.844426 |
work_keys_str_mv | AT panglijun reactiveoxygenspeciesresponsivenanococktailwithselfamplificateddrugreleaseforefficientcodeliveryofpaclitaxelcucurbitacinbandsynergistictreatmentofgastriccancer AT zhanglei reactiveoxygenspeciesresponsivenanococktailwithselfamplificateddrugreleaseforefficientcodeliveryofpaclitaxelcucurbitacinbandsynergistictreatmentofgastriccancer AT zhouhong reactiveoxygenspeciesresponsivenanococktailwithselfamplificateddrugreleaseforefficientcodeliveryofpaclitaxelcucurbitacinbandsynergistictreatmentofgastriccancer AT caoling reactiveoxygenspeciesresponsivenanococktailwithselfamplificateddrugreleaseforefficientcodeliveryofpaclitaxelcucurbitacinbandsynergistictreatmentofgastriccancer AT shaoyueqin reactiveoxygenspeciesresponsivenanococktailwithselfamplificateddrugreleaseforefficientcodeliveryofpaclitaxelcucurbitacinbandsynergistictreatmentofgastriccancer AT litengyun reactiveoxygenspeciesresponsivenanococktailwithselfamplificateddrugreleaseforefficientcodeliveryofpaclitaxelcucurbitacinbandsynergistictreatmentofgastriccancer |